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Abstract
Background: Central administration of g-amino butyric acid (GABA) induces lower body temperature in animals in
hot ambient air. However, it is still unknown whether oral GABA administration affects temperature regulation at
rest in a hot environment in humans. Therefore, in the present study, we specifically hypothesized that systemic
administration of GABA in humans would induce hypothermia in a hot environment and that this response would
be observed in association with decreased heat production.
Methods: Eight male participants drank a 200-ml sports drink with 1 g of GABA (trial G) or without GABA (trial C), then
rested for 30 minutes in a sitting position in a hot environment (ambient air temperature 33°C, relative humidity 50%).
Results: We found that changes in esophageal temperature from before drinking the sports drink were lower in
trial G than in trial C (-0.046 ± 0.079°C vs 0.001 ± 0.063°C; P < 0.05), with lower heat production calculated by
oxygen consumption (41 ± 5 W/m
2 vs 47 ± 8 W/m
2; P < 0.05).
Conclusions: In this study, we have demonstrated that a single oral administration of GABA induced a larger
decrease in body core temperature compared to a control condition during rest in a hot environment and that
this response was concomitant with a decrease in total heat production.
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Background
g-aminobutyric acid (GABA)i sa na m i n oa c i dt h a ti s
widely distributed throughout the central nervous sys-
tem (CNS) and is the most important depressive neuro-
transmitter [1]. GABA has important roles concerning
temperature regulation in the hypothalamus. In experi-
mental animals, it has been reported that central phar-
macological stimulation of GABA in the dorsomedial
hypothalamus (DMH) and the posterior hypothalamus
(PH) inhibits heat production [2,3]. On the contrary, it
has been reported that central pharmacological stimula-
tion of GABA in the preoptic (PO) area and anterior
hypothalamus (AH) increases heat production [4,5]. On
the basis of these reports, it is assumed that central
GABA stimulation to the hypothalamic region has some
practical effect on temperature regulation.
Few studies have examined the influence of systemic
GABA stimulation on temperature regulation in either
experimental animals or humans because the blood-
brain barrier is impermeable to GABA [6] and it has
long been thought that systemic administration of
GABA cannot affect GABA’s availability in the CNS
[7,8]. However, it has been suggested that GABA could
access certain areas of the brain that lack the blood-
brain barrier [9-11], such as the hypothalamus. There-
fore, it is expected that systemically administered GABA
affects GABA’s availability in the hypothalamus and may
have effects on the responses of temperature regulation
in humans, as reported with regard to central pharma-
cological stimulation in experimental animals.
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laboratory, we have reported that oral GABA administra-
tion might induce lower core temperature during rest
under a hot environment [12]. However, because our pre-
vious study was focused on the effect of oral GABA
administration during exercise, we derived insufficient
data to clarify the effect of oral GABA administration dur-
ing rest. For example, the elapsed time from GABA
administration differed among the subjects because the
beginning of the rest period was determined to be the
time at which the core temperature returned to the base-
line level after sample ingestion. Furthermore, it is thought
that subjects were under a certain amount of mental or
physical stress because they maintained a semirecumbent
position with their feet on riding pedals to be ready for
exercise and had a catheter inserted into the left antecubi-
tal vein for blood sampling. Such physical and/or mental
stresses could affect physiological parameters. Therefore, it
is still unknown whether oral GABA administration affects
temperature regulation at rest in a hot environment. In the
present study, we specifically hypothesized that systemic
administration of GABA in humans would induce
hypothermia in a hot environment and that this response
would be observed in association with decreased heat pro-
duction. To test these hypotheses in the present study, we
compared temperature-regulatory responses in resting
humans in a hot environment between two trials: after
oral GABA administration and after placebo administra-
tion. If we could detect the hypothermic effect of systemic
administration of GABA in a hot environment in humans,
we expected that oral GABA administration would be
used to prevent hyperthermia and the resulting heat disor-
ders that occur during high-temperature conditions, such
as during the summer.
Methods
Participants
Eight healthy nonsmoking men who usually exercised 3
to 5 days per week were included in this study. Their
physical characteristics were age 23.5 ± 3.6 years, height
172.6 ± 3.5 cm, weight 66.9 ± 7.4 kg, body mass index
22.5 ± 2.7 kg/m
2 (all means ± SD). Written informed
consent was obtained from all participants before parti-
cipation in this study. The study protocol and the
informed consent forms, which conformed to the guide-
lines of the Declaration of Helsinki, were approved by
the Ethics Committee of the Graduate School of Medi-
cine at Osaka City University.
Experimental design
This study was carried out using a placebo-controlled,
double-blind design. The participants randomly per-
formed two trials, a control trial (trial C) and a GABA
trial (trial G). The trials were conducted at the same
time of day with an interval of at least 3 days between
trials to avoid the influence of circadian variation. All
experiments were conducted in the morning during the
winter season (from January to March). The participants
ingested a 200-ml sports drink (placebo) in trial C and a
200-ml sports drink containing 1 g of GABA (GABA
drink) in trial G. The dose was the maximal consump-
tion of GABA for a single ingestion (Japan Standard
Commodity Classification 872199). Both the placebo
a n dt h eG A B Ad r i n kw e r es t o r e da tr o o mt e m p e r a t u r e
controlled at 23°C to 25°C. We checked and confirmed
that the temperature of each fluid was 21°C to 23°C
before the participants drank it. The sports drink (200
ml) provided 30 kcal of energy, 7.4 g of carbohydrate, 0
g of protein and 0 g of fat.
Protocols
The participants were requested to refrain from consum-
ing food or drink for at least 12 hours and to avoid caffei-
nated beverages, alcohol and strenuous physical activity
for at least 24 hours before each experiment. Consump-
tion of drinking water was permitted as required. The
participants reported to the laboratory at 10:00 AM.
They were asked to drink water (200 ml) and then sit for
30 minutes to achieve a normal body fluid balance. They
then voided, were weighed in the nude and were pro-
vided a pair of shorts. They then swallowed an esopha-
geal thermistor. Subsequently, they entered the climatic
chamber (TBR-6W2S2L2M; ESPEC Corp, Osaka, Japan)
maintained at an ambient temperature (Ta) of 33°C and
50% relative humidity. The participants sat for 1 hour on
chairs without backrests while measurement devices
were positioned. After baseline data correction for 5 min-
utes and confirmation of stable physiological responses
before drinking, the participants ingested the placebo in
trial C and the GABA drink in trial G within 1 minute.
They were then instructed to rest in a sitting position for
30 minutes. Because we had confirmed that plasma
GABA concentration increased after oral administration
of GABA, peaked 20 to 40 minutes after ingestion and
maintained significantly higher levels than the baseline
for at least 1 hour [12], we set the rest period for 30 min-
utes in this study. During the rest period, an examiner in
close proximity to each subject paid close attention to
prevent a reduction in the subject’sa r o u s a ll e v e lb y
checking the subject’s heart rate and facial expression.
After the rest period, the monitoring instruments were
promptly removed, and the participants exited the cham-
ber, wiped themselves down and were weighed again in
the nude to estimate total sweat loss.
Measurements
Esophageal temperature (Tes) was measured using the
esophageal thermistor inserted into a polyethylene tube
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tube was advanced through the external nares to a dis-
tance of one-fourth the participant’s standing height.
Skin temperature was measured using thermistors (LT-
ST08-12; Gram Co) placed on the chest (Tchest), upper
arm (Tarm), thigh (Tthigh)a n dl e g( T leg)o nt h el e f ts i d e .
Mean skin temperature (Tsk) was calculated from the
body surface area distribution and thermal sensitivity of
each skin area using the following formula, which was
proposed by Ramanathan [13]:
Tsk =0 . 3 ( T chest +T arm) + 0.2(Tthigh +T leg)
Ta was measured using a thermister (LT-ST08-12;
Gram Co) in the climate chamber at the same level of
the chest thermister. The precision of LT-ST08-11 and
LT-ST08-12 was ± 0.01°C. Heart rate (HR) measured by
electrocardiography and blood pressure measured by
oscillometry were measured noninvasively every minute
(BSM-4103; Nihon-Kohden, Tokyo, Japan). Mean arter-
ial pressure (MAP) was calculated as one-third of the
p u l s ep r e s s u r ep l u st h ed i a s tolic blood pressure. Skin
blood flow was measured on the chest (SkBFchest)o n
t h el e f ts i d eb yl a s e rD o p p l e rf l o w m e t r y( A L F 2 1 D ;
Advance, Tokyo, Japan). Sweat rate was measured on
the chest (SRchest) on the left side using the ventricular
capsule method (SS-100ΙΙ;Ka n dS ,A i c h i ,J a p a n ) .T h e
flow rate and duration of air ventilation before starting
measurement were 0.3 ml/minute and 10 minutes,
respectively. The precision of the SS-100ΙΙ for SR mea-
surements was ± 3% within the range of 0 to 5 mg/cm
2/
minute. For each participant, the probe and capsule
were placed on the skin at identical sites in both trials.
Data for Tes, skin temperature, Ta, SkBFchest and SRchest
were collected at intervals of 1 second using a 16-chan-
nel computerized data acquisition system (Intercross-
310; Intercross Co, Tokyo, Japan) and stored in data
files on a laboratory computer (JPA32301WP; Hewlett-
Packard Japan Ltd, Tokyo, Japan). Oxygen consumption
(VO2) was measured at 20-second intervals using a
metabolic gas analyzer system (Vmax Encore 29 System;
VIASYS Healthcare, Inc, Yorba Linda, CA, USA). The
coefficient of variation for VO2 measurement by the
Vmax Encore 29 System was 3%. Total sweat loss was
estimated by determining the change in dry body weight
(BW), which was measured immediately before and after
the experiment as (BWbefore)-( B W after) + 200 g (weight
of drink). There was no significant difference in BWbefore
between trial C and trial G (66.96 ± 7.47 kg vs 66.88 ±
7.45 kg; P = 0.36).
The absolute values and the changes from baseline of
Tes and Tsk between 30 minutes of rest were compared
between trials. SkBFchest values were expressed as per-
centage changes from the value before drinking (%
SkBFchest =( S k B F chest/before drinking SkBFchest) × 100)
because absolute values within an individual can vary
markedly over the surface of the skin [14]. We averaged
the recorded signals in 5-minute time windows.
We calculated the rate of radiant (R), convective (C),
conductive (K) and evaporative (E) heat loss (W/m
2)
from the skin surface to the environment using the fol-
lowing equations presented in a previous study [15]:
R=h r(Tsk − Ta),
C=h c(Tsk − Ta),
K=h k(Tsk − Ta)a n d
E=h e(Pdp − Psk),
where hr,h c,h k and he are radiant, convective, con-
ductive and evaporative coefficient of heat transfer,
respectively. Pdp is vapor pressure of room air calculated
by Ta and RH, and Psk is saturated vapor pressure at
Tsk. Total heat loss was calculated by summarizing R, C,
K and E. Furthermore, we calculated the rate of meta-
bolic energy production as total heat production (M)
using the following equation presented previously [15]:
M=( 0 . 2 3× RER + 0.77)(5.873)(VO2)(60/Ad),
where RER is the respiratory exchange ratio, VO2 is
oxygen uptake, Ad is body surface area and 5.873 is oxy-
gen energy equivalent. Heat loss and production were
calculated every 1 minute and averaged over time win-
dows of 5 minutes and per 30 minutes.
Statistical analysis
Two-way (trial-by-time) repeated-measures analysis of
variance (ANOVA) was performed to test the effects of
GABA administration over time. Subsequent post hoc
tests to determine significant differences in the various
pairwise comparisons were performed using Tukey’s
post hoc test. There was a transient reduction in Tes
after drinking. This response may be due to the sample
ingestion and may not be related to GABA effect.
Furthermore, this outlier might disturb the interpreta-
tion of our statistical analysis. Therefore, the data for
Tes at 5 minutes were excluded from statistical analyses.
Ap a i r e dt-test was used to assess differences in heat
production, heat loss and total sweat loss between trials.
These statistical analyses were computed using Sigma-
Stat version 3.5 software (Systat Software Inc, Chicago,
IL, USA). P < 0.05 was considered statistically signifi-
cant. The data are presented as means ± SD unless sta-
ted otherwise.
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Ta during 30 minutes of measurement was maintained at
33.01°C to 33.77°C (range of minute average). The abso-
lute values of Tes and Tsk at 0 minutes were not signifi-
cantly different between trial C and trial G (Tes = 36.70 ±
0.16°C vs 36.75 ± 0.23°C, P = 0.40; Tsk = 34.37 ± 0.55°C
vs 34.46 ± 0.47°C, P =0 . 6 0 ) .T h et i m ec o u r s eo fT es is
s h o w ni nF i g u r e1( F i g u r e1 A ,a b s o l u t ev a l u e ;F i g u r e1 B ,
change from 0-minute value). There was a transient
r e d u c t i o ni nT es after drinking. This response may be
due to the sample ingestion and may not be related to a
GABA effect. Furthermore, this outlier might disturb the
interpretation of the statistical analysis. Therefore, the
data at 5 minutes were excluded from statistical analyses.
In trial C, ΔTes returned to the same temperature as at
0 minutes after the transient reduction and values at
15 to 30 minutes were not significantly different from
those at 0 minutes. However, ΔTes at 25 to 30 minutes
was significantly higher than at 10 minutes. In trial G,
ΔTes at 15 to 30 minutes returned to the same tempera-
ture as at 0 minutes, and these values were not signifi-
cantly different from those at 10 minutes. Furthermore,
ΔTes in trial G was significantly lower than that in trial C
at 25 to 30 minutes. There were no significant differences
between trials and times in absolute values of Tes.
F i g u r e2i l l u s t r a t e st h et i m ec o u r s eo fT sk during
30 minutes of rest (Figure 2A, absolute value; Figure 2B,
change from 0-minute value). There was no significant
difference in absolute values and changes from 0-minute
data for Tsk between trials and times. The time course of
VO2 is shown in Figure 3. VO2 was slightly lower in trial
G than in trial C, although there was no significant
difference.
Table 1 shows the values of %SkBFchest,S R chest,H R
and MAP. At 30 minutes, %SkBFchest,S R chest and HR
w e r eu n c h a n g e df r o ma t0m i n u t e st h r o u g h o u tt h et e s t
in both trials and were not significantly different
between trials at any time point. MAP at 30 minutes
decreased significantly compared with 0 minutes in
both trials. Total sweat loss was marginally lower in
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Figure 1 Time course of esophageal temperature (Tes)( A ,
absolute value; B, change from 0-minute value) during 30
minutes of rest in trial C (white) and trial G (black). Values are
means ± SD for eight participants. *P < 0.05, significant difference
between trial C and trial G.
†,‡P < 0.05, significant difference from 0
minutes and 10 minutes, respectively.
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Figure 2 Time course of mean skin temperature (Tsk)( A ,
absolute value; B, change from 0 min value) during 30 min of
rest in trial C (white) and trial G (black). Values are means ± SD
for eight participants.
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0.101).
Figure 4 illustrates the time course of heat production
(Figure 4A) and heat loss (Figure 4B) during 30 minutes of
rest. Heat production was slightly lower in trial G than in
trial C, although there was no significant difference. There
was no significant difference in heat loss between trials and
times.
The rate of heat production averaged per 30 minutes
in trial G was significantly lower than that of trial C.
The rate of heat loss averaged per 30 minutes in trial G
was approximately 33% higher than in trial C, but there
was no significant difference (Figure 5).
Discussion
The major findings of the present study are that oral
administration of GABA induced a decrease in body
core temperature compared to control conditions during
rest in a hot environment and that this response was
concomitant with a decrease in total heat production.
The most intriguing result of the present study is that
the ΔTes values in trial G at 25 to 30 minutes were signif-
icantly lower than those in trial C, as shown in Figure 1,
suggesting that oral administration of GABA induced
responses to decrease body core temperature in resting
humans in a hot environment. In the conditions of the
present study, body core temperature was determined by
the balance of heat production with resting metabolism
and heat gain from or loss to the environment, such as
by radiant, convective and evaporative heat exchange
[ 1 5 ] .A ss h o w ni nF i g u r e s4a n d5 ,a l t h o u g ht h e r ew e r e
no significant differences in the time course of heat pro-
duction between trial C and trial G, we observed that
heat production averaged per 30 minutes in trial G was
lower than that in trial C. Furthermore, although there
Table 1 Physiological variables
a
Trial C Trial G
Variables 0 minutes 30 minutes 0 minutes 30 minutes
%SkBFchest (%) 100 125 ± 49 100 112 ± 19
SRchest (mg/cm
2/minute) 0.14 ± 0.05 0.22 ± 0.13 0.27 ± 0.20 0.23 ± 0.12
HR (bpm) 70 ± 7 71 ± 12 72 ± 11 75 ± 14
MAP (mmHg) 80 ± 9 71 ± 9
b 78 ± 9 70 ± 10
b
a%SkBFchest, percentage change in chest skin blood flow; bpm, beats per minute; SRchest, chest sweat rate; HR, heart rate; MAP, mean arterial pressure.
bP < 0.05,
significant difference from levels at 0 minutes. Values are means ± SD for eight participants.
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Figure 3 Time course of oxygen consumption (VO2) during 30
minutes of rest in trial C (white) and trial G (black). Values are
means ± SD for eight participants.
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Figure 4 Time course of heat production (A) and heat loss (B)
during 30 minutes of rest in trial C (white) and trial G (black).
Values are means ± SD for eight participants.
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trial G were lower than those in trial C from 15 minutes
(Figure 3). These data suggest that oral administration of
GABA decreased heat production with lowering resting
metabolism and therefore decreased the body core tem-
perature. However, it is still unknown how the differ-
ences in heat production contribute to the differences in
body core temperature. Further studies are needed to
more clearly explain the relation between heat produc-
tion and body core temperature changes.
The responses of ΔTes and heat production with oral
administration in the present study are experimentally
similar to previous observations in animals by showing
that central pharmacological stimulation of GABA in
the DMH and PH inhibits heat production [2,3]. Neu-
rons in the DMH play key roles in temperature regula-
tion. The activation of DMH elevates core temperature
and sympathetic activity to interscapular brown adipose
tissue in conscious rats. Microinjection of the GABAA
receptor agonist muscimol into DMH suppresses
increases in sympathetic nerve activity to interscapular
brown adipose tissue. In a similar way, the PH can acti-
vate an autonomic mechanism controlling heat produc-
tion in brown adipose tissue. Furthermore, the neural
mechanism in the PH mediating this effect is tonically
inhibited by GABA. Thus the observations that we pre-
sent indirectly support the hypothesis that orally admi-
nistered GABA circulates in the bloodstream and affects
GABA concentration and/or the activation of GABA
function in the CNS through the region which lacks the
blood-brain barrier [9-11] and induces the same effects
for the region relating to temperature regulation, such
as DMH and PH. However, we found no evidence that
orally administered GABA affected central GABA
concentration or function in either animals or humans.
Additionally, it has been reported in animal studies that
when the GABA agonist muscimol perfuses into the
PO/AH, heat production and body core temperature are
increased in various environmental conditions [4,5].
Therefore, further studies are necessary to elucidate the
relationship between the oral administration of GABA
and central GABA function in humans as well as in
animals.
Limitations
The present study has some limitations. First, we did not
measure plasma GABA concentrations. We confirmed
that plasma GABA concentrations increased after oral
administration of GABA, peaked 20 to 40 minutes after
ingestion and maintained significantly higher levels than
the baseline for at least 1 hour [12]. Therefore, to dimin-
ish any subject’s stress as a result of placing the catheter,
we set a rest period of 30 minutes in this study by refer-
ence to the previous study. Second, we verified the effect
of only one amount of GABA. To clarify the whole pic-
ture of the effect of GABA, it is necessary to investigate
the effect of other amounts of GABA and reveal the con-
centration dependency.
Conclusions
In this study, we have demonstrated that a single oral
administration of GABA induced a decrease in body
core temperature compared to control condition during
rest in a hot environment and that this response was
concomitant with a decrease in total heat production.
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